The utility of the ACR/EULAR 2017 provisional classification criteria for granulomatosis with polyangiitis in Korean patients with antineutrophil cytoplasmic antibody-associated vasculitis

被引:2
作者
Yoo, J. [1 ]
Kim, H. J. [1 ]
Ahn, S. S. [1 ]
Jung, S. M. [1 ]
Song, J. J. [1 ]
Park, Y. -B. [1 ]
Lee, S. -W. [1 ]
机构
[1] Yonsei Univ, Coll Med, Dept Internal Med, Div Rheumatol, 50-1 Yonsei Ro, Seoul 03722, South Korea
关键词
ANCA-associated vasculitis; ACR/EULAR 2017 classification criteria for GPA; RHEUMATOLOGY; 1990; CRITERIA; CHURG-STRAUSS-SYNDROME; MICROSCOPIC POLYANGIITIS; SYSTEMIC VASCULITIS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. We applied the ACR/EULAR 2017 provisional classification criteria for granulomatosis with polyangiitis (GPA) to 150 Korean patients with previously diagnosed antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) and investigated how many patients with AAV were reclassified as GPA. Methods. We included patients with 30 GPA, 30 eosinophilic GPA (EGPA) and 90 microscopic polyangiitis (MPA) patients. Patients can be classified as GPA, when the sum of scores is more than 5. Results. At diagnosis the mean age of 150 patients with AAV was 60.1 years old, and 101 patients (67.3%) were women. Overall, 33 of 150 patients with AAV (22.0%) were classified as GPA according to the 2017 provisional criteria for GPA. The 2017 provisional criteria for GPA dropped to 10.0% of previously diagnosed GPA patients and the major factor to drop 3 GPA patients was the deletion of 2 items of the 1990 criteria, urinary sediment and infiltrates on chest radiograph. Meanwhile, one of 30 patients with EGPA (3.3%) and 5 of 90 patients with MPA (5.6%) were newly classified as GPA based on the 2017 provisional criteria for GPA. We could also find that items of the 2017 provisional criteria to contribute to reclassifying EGPA and MPA patients as GPA were PR3-ANCA, mass-like lung lesion and nasal congestion in Korean patients with AAV. Conclusion. The use of the 2017 provisional criteria for GPA excluded 10.0% of previously classified GPA patients and newly classified 3.3% of EGPA patients and 5.6% of MPA patients as GPA in Korean patients with AAV.
引用
收藏
页码:S85 / S87
页数:3
相关论文
共 50 条
  • [21] Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis
    McGregor, JulieAnne G.
    Hogan, Susan L.
    Kotzen, Elizabeth S.
    Poulton, Caroline J.
    Hu, Yichun
    Negrete-Lopez, Roberto
    Kidd, Jason M.
    Katsanos, Suzanne L.
    Bunch, Donna O.
    Nachman, Patrick H.
    Falk, Ronald J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 : i123 - i131
  • [22] Renal Involvement in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Zonozi, Reza
    Niles, John L.
    Cortazar, Frank B.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2018, 44 (04) : 525 - +
  • [23] Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis
    Moran, Sarah
    Little, Mark A.
    CURRENT OPINION IN RHEUMATOLOGY, 2014, 26 (01) : 37 - 41
  • [24] Predictor of depressive disorders in patients with antineutrophil cytoplasmic antibody-associated vasculitis
    Yun, Jan-Di
    Ha, Junghee
    Kim, Solah
    Park, Hyung Ah
    Yoo, Juyoung
    Ahn, Sung Soo
    Jung, Seung Min
    Song, Jason Jungsik
    Park, Yong-Beom
    Lee, Sang-Won
    CLINICAL RHEUMATOLOGY, 2019, 38 (12) : 3485 - 3491
  • [25] Proposal for a more practical classification of antineutrophil cytoplasmic antibody-associated vasculitis
    Oliva-Damaso, Nestor
    Bomback, Andrew S.
    CLINICAL KIDNEY JOURNAL, 2021, 14 (05) : 1327 - 1334
  • [26] Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Berti, Alvise
    Warner, Roscoe
    Johnson, Kent
    Cornec, Divi
    Schroeder, Darrell
    Kabat, Brian
    Langford, Carol A.
    Hoffman, Gary S.
    Fervenza, Fernanado C.
    Kallenberg, Cees G. M.
    Seo, Philip
    Spiera, Robert
    St Clair, E. William
    Brunetta, Paul
    Stone, John H.
    Merkel, Peter A.
    Specks, Ulrich
    Monach, Paul A.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70 (07) : 1114 - 1121
  • [27] Profiles of cytokines in patients with antineutrophil cytoplasmic antibody-associated vasculitis
    Hao, Weiwei
    Li, Wei
    Wang, Xiaoying
    Dong, Fang
    Liu, Peiling
    Zhang, Xin
    Liu, Rui
    Li, Tianfang
    Zhang, Lei
    Liu, Shengyun
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [28] Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study
    Sada, Ken-ei
    Yamamura, Masahiro
    Harigai, Masayoshi
    Fujii, Takao
    Dobashi, Hiroaki
    Takasaki, Yoshinari
    Ito, Satoshi
    Yamada, Hidehiro
    Wada, Takashi
    Hirahashi, Junichi
    Arimura, Yoshihiro
    Makino, Hirofumi
    ARTHRITIS RESEARCH & THERAPY, 2014, 16 (02)
  • [29] Thai Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Outcomes and Risk Factors for Mortality
    Intapiboon, Porntip
    Siripaitoon, Boonjing
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 (08) : E378 - E384
  • [30] Bronchiectasis in patients with antineutrophil cytoplasmic antibody-associated vasculitis: a case control study on clinical features and prognosis
    Ren, Jiaqi
    Ding, Yanling
    Zhao, Jinxia
    Sun, Yongchang
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2022, 16 (06) : 697 - 705